Provexis (PXS)

 

Latest News

Grant of Share Options

RNS Number: 6272A Provexis PLC 29 December 2017 29 December 2017 Provexis plc Grant of Share Options Provexis plc ('Provexis' or the 'Company'), the business that develops, licenses and sells the proprietary, scientifically-proven Fruitflow heart-health functional food ingredient, announces that it has today awarded a total of 27,500,000 options ("Options") over or...

Provexis struggles to grow revenue as it reports half year results

Provexis has reported 124,259 revenue for the six months to 30 September 2017, barely above the 123,456 it generated in the ...

Half-year Report

RNS Number: 5466A Provexis PLC 29 December 2017 29 December 2017 Provexis plc UNAUDITED INTERIM RESULTS FOR SIX MONTHS TO 30 SEPTEMBER 2017 Provexis plc (" Provexis " or the " Company "), the business that develops, licenses and sells the proprietary, scientifically-proven Fruitflow heart-health functional food ingredient, announces its unau...

Patent application - Fruitflow and air pollution

RNS Number: 2215Y Provexis PLC 04 December 2017 4 December 2017 Provexis plc Patent application - Fruitflow protects against adverse effects of air pollution Provexis plc ('Provexis' or the 'Company'), the business that develops, licenses and sells the proprietary, scientifically-proven Fruitflow heart-health functional food ingredient, is delighted to announce the filin...

All News

DateHeadlineSource
07-03-14Boohoo IPO raises relationship red flagInteractive Investor
17-02-14Provexis changes registered office StockMarketWire
17-12-13Provexis narrows H1 pretax lossStockMarketWire
03-12-13Provexis schedules interims StockMarketWire
19-11-13Trends and Targets for 20/11/2013Trends and Targets
18-11-13Provexis notes share price moveStockMarketWire
17-11-13Trends and Targets for 18/11/2013Trends and Targets
14-11-13Trends and Targets for 15/11/2013Trends and Targets
13-11-13Trends and Targets for 14/11/2013Trends and Targets
12-11-13Trends and Targets for 13/11/2013Trends and Targets
11-11-13Trends and Targets for 12/11/2013Trends and Targets
10-11-13Trends and Targets for 11/11/2013Trends and Targets
30-09-13Provexis has sufficient funds until early 2016StockMarketWire
11-09-13Provexis raises £0.29m via equity financing facilityStockMarketWire
08-08-13Provexis says Science in Sport demerger effectiveStockMarketWire
15-07-13Provexis demerger approved by shareholdersStockMarketWire
28-06-13Provexis grows its revenues by 60%StockMarketWire
27-06-13Provexis to demerge Science in Sport divisionStockMarketWire
31-07-12Markets: FTSE 100 tumbles on TuesdayInteractive Investor
14-02-12Markets: FTSE 100 endures unsteady TuesdayInteractive Investor
08-12-11Hybridan's Small Cap WrapHybridan
05-07-11Markets: FTSE 100 edges further aheadInteractive Investor
23-06-11Hybridan's Small Cap WrapHybridan
17-06-11Markets: Greek hopes help FTSE 100 recoverInteractive Investor
17-06-11Provexis slumps on full-year resultsInteractive Investor
01-06-11Markets: Weak data sends FTSE 100 lowerInteractive Investor
31-05-11Provexis climbs on positive full-year updateInteractive Investor
24-12-10Hybridan's Small Cap WrapHybridan

RSS feeds

  • Editorial news feed for LSE:PXS Editorial
  • Regulatory news feed for LSE:PXS Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account